A New Era for Clinical Research in Cameroon

Over the past two decades, Cameroon has emerged as a significant player in clinical research, particularly in studies targeting HIV, malaria, and neglected tropical diseases. A review of 2,172 biomedical research protocols approved in Cameroon from 1997 to 2012 showed that 61.3% focused on disease control, with HIV accounting for 25.8% and malaria for 10.3% of all studies. By 2019, the Cameroon Health Research and Evidence Database (CAMHRED) catalogued over 4,384 local health studies, reflecting a sustained and broad increase in research activity across the country. National efforts also prioritized neglected tropical diseases, with research highlighting high-risk rural populations and supporting new intervention programs. Historically, research in Cameroon was guided by international ethical benchmarks such as the Declaration of Helsinki and ICH Good Clinical Practice, before the country established a comprehensive national regulatory framework for clinical research. This gap became more apparent as international collaborations and funding increased, highlighting the urgent need for local oversight to protect clinical trial participants and ensure data integrity.

Cameroon is building a regulatory infrastructure that both fosters clinical research and protects public health. Here we explore the intersection of clinical research and regulatory affairs in Cameroon, illustrating progress with real-world examples, ongoing challenges, and future opportunities.

Historical Evolution: From International Oversight to National Accountability

Early Days and the Push for Local Governance
After Cameroon gained independence in 1960, clinical research in the country was largely driven by foreign researchers, with limited local oversight. The absence of national regulatory texts meant that studies were evaluated solely against international norms such as the Universal Declaration of Human Rights and the International Covenant on Civil and Political Rights.

A pivotal moment came in 1987, when Cameroonian researchers required ethics committee approval to access international funding. This led to the creation of Cameroon’s first ethics committee. However, the lack of a comprehensive regulatory framework persisted, resulting in inconsistent oversight and, at times, questionable research practices.

The Tenofovir Trial Scandal: A Catalyst for Reform
The need for stronger regulation became undeniable after the 2003 tenofovir trial scandal. The study, which aimed to test HIV prevention among sex workers, was suspended due to ethical violations, echoing concerns raised in Cambodia and elsewhere, as reported by international observers and local stakeholders. At the time, Cameroon’s ethics committee lacked independence, operational structure, and sufficient resources, making effective oversight nearly impossible.

Building the Regulatory Infrastructure: Laws, Committees, and Capacity

Legislative Milestones
Recognizing the urgent need for reform, the Ministry of Public Health established the Research Operations Division for the Protection of Participants in 2003. The real breakthrough came in 2012 with the creation of the National Committee on Research Ethics for Human Health (CNERSH), along with regional and institutional committees. These bodies were tasked with reviewing research protocols, monitoring studies, and protecting participant rights.

The momentum continued with the adoption of the 2022 Medical Research Law, which set out clear ethical standards, operational guidelines, and sanctions for noncompliance. This law covers a wide range of research activities, including those involving vulnerable populations such as minors, pregnant women, and incapacitated adults. It also emphasizes the accountability of both researchers and sponsors, promoting collaborative partnerships and transparency.

Decentralization and Local Empowerment
A key feature of Cameroon’s regulatory evolution has been the decentralization of ethics committees. Regional and institutional review boards now play a crucial role in ensuring that research conducted in diverse settings meets national and international standards. This approach supports greater oversight and responsiveness to local needs.

Ongoing Challenges: Capacity, Resources, and Harmonization

Despite impressive progress, several challenges remain:

• Limited Resources: Regulatory bodies often lack the financial and human resources needed for thorough oversight, including the ability to conduct field inspections.
• Variable Expertise: The quality and consistency of ethics review can vary across regions of Cameroon, sometimes due to insufficient training in research ethics.
• Harmonization Gaps: Cameroon’s regulatory system is still working toward full alignment with other African and international frameworks, such as the African Medicines Agency (AMA) and the African Vaccine Regulatory Forum (AVAREF).
• Digital Infrastructure: The absence of robust digital tools for trial registration and monitoring limits the ability to track and oversee ongoing research remotely.

Opportunities and Forward Momentum

Cameroon’s regulatory environment is poised for further improvement through several funded and ongoing initiatives:

• Capacity Building: Regular training programs—often in partnership with international bodies such as the World Health Organization (WHO), AVAREF, and the EDCTP—are actively building expertise and strengthening ethical awareness among regulators and researchers.
• Regional Collaboration: Cameroon participates in continental frameworks like the AMA and AVAREF, leveraging regulatory reliance models and the harmonization of standards to accelerate reviews and share best practices with other African countries.
• Digital Transformation: Development is underway for online platforms for clinical trials registration and oversight, aiming to streamline regulatory processes and enhance transparency, though full implementation remains a work in progress.
• Community Engagement: Initiatives to raise public awareness and involve local communities in health research governance are ongoing, ensuring that research aligns with national health priorities and builds public trust.

Key Points:

• Cameroon’s regulatory framework is now more robust and decentralized.
• The 2022 Medical Research Law provides clear ethical and operational guidelines.
• Ongoing challenges include resource constraints and the need for harmonization.
• Digital tools and regional partnerships are critical for future progress.

Looking Ahead

Cameroon has made significant strides in strengthening the legal and regulatory infrastructure for clinical research, shifting from a system reliant solely on international standards to one rooted in national laws and institutions. The creation and decentralization of ethics committees, combined with comprehensive legislation, have established a solid foundation for ethical and scientifically sound research.

Looking forward, continued investment in capacity building, digital infrastructure, and regional collaboration will be vital. Notably, Cameroon’s active participation in regional regulatory reliance initiatives—such as those led by AVAREF and the AMA—demonstrates the country’s commitment to working with trusted authorities across Africa to expedite reviews and bring innovative solutions to patients faster. As Cameroon’s regulatory system matures, it is increasingly poised to contribute to the global clinical research enterprise, not only as a research site but as a leader in ethical oversight, regulatory innovation, and regional cooperation.